---
category: news
title: "Biodesix to Present Data Supporting Proteomic-Based Immunotherapy Diagnostic Tests and AI Explainability in Diagnostic Tests at Society for Immunotherapy of Cancer Annual Meeting"
excerpt: "Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the company will"
publishedDateTime: 2021-11-12T16:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20211112005419/en/Biodesix-to-Present-Data-Supporting-Proteomic-Based-Immunotherapy-Diagnostic-Tests-and-AI-Explainability-in-Diagnostic-Tests-at-Society-for-Immunotherapy-of-Cancer-Annual-Meeting"
webUrl: "https://www.businesswire.com/news/home/20211112005419/en/Biodesix-to-Present-Data-Supporting-Proteomic-Based-Immunotherapy-Diagnostic-Tests-and-AI-Explainability-in-Diagnostic-Tests-at-Society-for-Immunotherapy-of-Cancer-Annual-Meeting"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "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;RPuvSPrXwagJaO2pH9u9iQ=="
---

